RENAISSANCE TECHNOLOGIES LLC
Institutional investor · Portfolio as of Q4 2020
Top Holdings3,342 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
NOVO-NORDISK A/S-SPONS ADR | 26.8M | $1.9B | 2.0% | $24.95 | +22.42% | 5 qtrssince 2019-Q4 | Decreased 0 |
BAIDU INC - SPON ADR | 8.6M | $1.9B | 2.0% | $114.27 | +92.20% | 5 qtrssince 2019-Q4 | Decreased 0 |
PDD HOLDINGS INC | 7.1M | $1.3B | 1.4% | $53.42 | +235.32% | 5 qtrssince 2019-Q4 | Decreased 0 |
VERISIGN INC | 5.7M | $1.2B | 1.3% | $190.67 | +11.52% | 5 qtrssince 2019-Q4 | Decreased 0 |
BRISTOL-MYERS SQUIBB CO | 18.5M | $1.1B | 1.2% | $49.04 | +1.53% | 5 qtrssince 2019-Q4 | Decreased 0 |
PALO ALTO NETWORKS INC | 3.1M | $1.1B | 1.2% | $38.57 | +53.75% | 5 qtrssince 2019-Q4 | Decreased 0 |
| 4.3M | $1B | 1.1% | — | — | 5 qtrssince 2019-Q4 | Decreased 0 | |
MONSTER BEVERAGE CORP | 10.2M | $946M | 1.0% | $31.20 | +48.22% | 5 qtrssince 2019-Q4 | Decreased 0 |
TARGET CORP | 5.3M | $943.7M | 1.0% | $100.92 | +48.17% | 5 qtrssince 2019-Q4 | Decreased 0 |
VERTEX PHARMACEUTICALS INC | 3.6M | $845.1M | 0.9% | $218.97 | +6.26% | 5 qtrssince 2019-Q4 | Decreased 0 |
CHIPOTLE MEXICAN GRILL INC | 593,242 | $822.7M | 0.9% | $16.59 | +67.16% | 5 qtrssince 2019-Q4 | Decreased 0 |
ZOOM COMMUNICATIONS INC | 2.4M | $805.7M | 0.9% | $211.17 | +67.35% | 4 qtrssince 2020-Q1 | Decreased 0 |
KROGER CO | 24.6M | $782.8M | 0.9% | $27.75 | +1.12% | 5 qtrssince 2019-Q4 | Decreased 0 |
BIOGEN IDEC INC | 3M | $743.8M | 0.8% | $296.73 | -17.48% | 5 qtrssince 2019-Q4 | Decreased 0 |
FRANCO-NEVADA CORP /CAD/ | 5.5M | $694.6M | 0.8% | $102.93 | +17.07% | 5 qtrssince 2019-Q4 | Increased 46 |
ETSY INC | 3.8M | $681.4M | 0.7% | $52.30 | +250.28% | 5 qtrssince 2019-Q4 | Increased 46 |
MOLINA HEALTHCARE INC | 3.1M | $659.4M | 0.7% | $135.84 | +52.21% | 5 qtrssince 2019-Q4 | Decreased 0 |
ABBVIE INC | 6.1M | $649.6M | 0.7% | $69.97 | +22.82% | 5 qtrssince 2019-Q4 | Decreased 0 |
ABIOMED INC | 2M | $646.4M | 0.7% | — | — | 5 qtrssince 2019-Q4 | Decreased 0 |
ALEXION PHARMACEUTICALS INC | 4.1M | $642.7M | 0.7% | — | — | 5 qtrssince 2019-Q4 | Decreased 0 |
RENAISSANCE TECHNOLOGIES LLC manages $92.1B across 3342 positions as of Q4 2020. Top holdings: NVO (2.0%), BIDU (2.0%), PDD (1.4%). Fund DNA: Diversified Scout. HoldingsIntel Rating: 2/5.0.
Active quarter - 600 new positions, 592 exits, 1125 increased. Top move: FNV (INCREASED, conviction 46). Portfolio: $92.1B across 3342 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer